Targeting impaired adult hippocampal neurogenesis in ageing by leveraging intrinsic mechanisms regulating Neural Stem Cell activity.

Adult neurogenesis Diseases of ageing Hippocampus Metabolism Neural stem cells Proteostasis

Journal

Ageing research reviews
ISSN: 1872-9649
Titre abrégé: Ageing Res Rev
Pays: England
ID NLM: 101128963

Informations de publication

Date de publication:
11 2021
Historique:
received: 07 04 2021
revised: 14 07 2021
accepted: 10 08 2021
pubmed: 18 8 2021
medline: 12 10 2021
entrez: 17 8 2021
Statut: ppublish

Résumé

Deficits in adult neurogenesis may contribute to the aetiology of many neurodevelopmental, psychiatric and neurodegenerative diseases. Genetic ablation of neurogenesis provides proof of concept that adult neurogenesis is required to sustain complex and dynamic cognitive functions, such as learning and memory, mostly by providing a high degree of plasticity to neuronal circuits. In addition, adult neurogenesis is reactive to external stimuli and the environment making it particularly susceptible to impairment and consequently contributing to comorbidity. In the human brain, the dentate gyrus of the hippocampus is the main active source of neural stem cells that generate granule neurons throughout life. The regulation and preservation of the pool of neural stem cells is central to ensure continuous and healthy adult hippocampal neurogenesis (AHN). Recent advances in genetic and metabolic profiling alongside development of more predictive animal models have contributed to the development of new concepts and the emergence of molecular mechanisms that could pave the way to the implementation of new therapeutic strategies to treat neurological diseases. In this review, we discuss emerging molecular mechanisms underlying AHN that could be embraced in drug discovery to generate novel concepts and targets to treat diseases of ageing including neurodegeneration. To support this, we review cellular and molecular mechanisms that have recently been identified to assess how AHN is sustained throughout life and how AHN is associated with diseases. We also provide an outlook on strategies for developing correlated biomarkers that may accelerate the translation of pre-clinical and clinical data and review clinical trials for which modulation of AHN is part of the therapeutic strategy.

Identifiants

pubmed: 34403830
pii: S1568-1637(21)00194-X
doi: 10.1016/j.arr.2021.101447
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101447

Informations de copyright

Copyright © 2021 Merck Sharp and Dohme Corp. Published by Elsevier B.V. All rights reserved.

Auteurs

Sébastien Gillotin (S)

MSD, London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH, UK. Electronic address: sebastien.gillotin@msd.com.

Vishal Sahni (V)

MSD, London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH, UK.

Tjaša Lepko (T)

MSD, London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH, UK.

Maya A Hanspal (MA)

MSD, London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH, UK.

Jina E Swartz (JE)

MSD, 2 Pancras Square, London, N1C 4AG, UK.

Zoi Alexopoulou (Z)

MSD, 2 Pancras Square, London, N1C 4AG, UK.

Fiona H Marshall (FH)

MSD, London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH